Xeris Pharmaceuticals Inc Cash Flow Reinvestment Rate
Xeris Pharmaceuticals Inc cash flow reinvestment rate. Xeris Pharmaceuticals Inc (XERS) has a Cash Flow Reinvestment Rate of 0.03x as of June 2026, reinvesting $209.00K (capex $209.00K ) from operating cash flow of $8.26 Million. Explore XERS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Xeris Pharmaceuticals Inc (2025–2025)
Cash flow reinvestment rate of Xeris Pharmaceuticals Inc from 2025 to 2025. Historical reinvestment intensity for Xeris Pharmaceuticals Inc across 1 annual periods. Explore Xeris Pharmaceuticals Inc (XERS) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Xeris Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2025–2025)
Xeris Pharmaceuticals Inc cash flow reinvestment rate by year from 2025 to 2025. Year-by-year capital reinvestment analysis for Xeris Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Xeris Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.02x | $696.00K | $28.63 Million | $696.00K | — |